Event to Raise Awareness of Clinical Experiences with Expanded Line of MatriStem® Advanced Wound Care Products
Columbia, MD – (May 30, 2014) – ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it will sponsor an educational lecture at the upcoming Wound, Ostomy and Continence Nurses Society Annual Conference in Nashville, Tennessee. The lecture will focus on urinary bladder matrix (UBM) technology as the next generation in complex wound management.
Event: Emerging Technologies in Regenerative Medicine
Presenter: Dan Davis, DPM, Podiatric Surgeon
Date: June 23, 2014
Time: 7:30 PM – 10:00 PM
Location: Omni Nashville Hotel
Jim DeFrancesco, Chief Executive Officer, said, “MatriStem Advanced Wound Care products address a growing need in acute and chronic wound management. We are pleased to be partnering with Dr. Davis as part of our national clinician education program, which proactively seeks to increase awareness and understanding of UBM technology, and its unique, differentiating properties.”
ACell released MatriStem Multilayer Wound Matrix for deep, hard-to-heal full-thickness wounds in February 2014 to complement its MatriStem Wound Matrix and MicroMatrix® devices. MatriStem Wound Care products are medical devices that maintain and support a healing environment through constructive remodeling.
MatriStem devices have received multiple 510(k) clearances from the FDA and are indicated for wound management including for pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds and trauma wounds, and the reinforcement of soft tissue where weakness exists in urological, gynecological and gastroenterological anatomy.
Comprised of naturally-occurring urinary bladder matrix (UBM), ACell’s MatriStem products are medical devices that maintain and support a healing environment through constructive remodeling. MatriStem maintains an intact epithelial basement membrane which is hypothesized to facilitate the body’s natural healing potential.
ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix products to repair and remodel damaged tissues in a broad range of applications. Its patented MatriStem ECM medical devices maintain and support a healing environment through constructive remodeling and are available in particle and sheet forms for the treatment of acute wounds and various surgical procedures. For more information, visit www.acell.com.
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products. Its medical devices are cleared for a variety of indications and are marketed under the brand name “MatriStem.” A privately held company, ACell produces MatriStem at its full scale manufacturing facilities in Columbia, MD and Lafayette, IN, and markets its products to physicians in the U.S. through a national direct sales force. For more information, call (800) 826-2926 or visit www.acell.com.
MatriStem products are porcine-derived extracellular matrix (ECM), essential structures that maintain and support a healing environment through constructive tissue remodeling. All MatriStem devices contain the basement membrane of porcine urinary bladder tissue, or urinary bladder matrix (UBM). UBM is a layer of tissue that is a critical component of constructive tissue remodeling. It provides MatriStem products with several distinguishable characteristics, including the ability to facilitate the body’s own regenerative capabilities and help restore normal site-appropriate tissue while avoiding scar tissue formation; the ability to be used “off-the-shelf” and stored at room temperature, with an approximate two year shelf life; and superior ease-of-use characteristics. MatriStem products are indicated for use in a wide range of regenerative and tissue repair applications and come in a range of sizes and thicknesses. It is the only ECM of its kind available in micronized particulate form. It has been cleared for use for the reinforcement of soft tissue where weakness exists in urological, gynecological and gastroenterological anatomy, which is referred to as surgical soft tissue repair, and for the management of wounds, such as pressure ulcers, venous ulcers, diabetic ulcers, second-degree burns, surgical wounds and trauma wounds, which is referred to as complex wound management. Refer to IFU supplied with each device for indications, contraindications, and precautions. All MatriStem devices are made in the USA.Return to News